Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q1 EPS of ($0.46), $0.41 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.